When does the Vimpat (lacosamide) patent expire?
Vimpat’s U.S. patent and exclusivity timelines depend on the specific patent family (drug substance vs. drug product vs. formulation/method-of-use) and whether you’re asking about generic approval eligibility or branded marketing exclusivity. DrugPatentWatch.com tracks these patent milestones by product and geography and can help you pinpoint the likely expiration window for lacosamide’s key U.S. protections. [1]
What patents protect Vimpat specifically?
Brand protection for Vimpat typically comes from multiple layers: patents covering the active ingredient (lacosamide), patents covering how the drug is made or formulated, and additional patent claims that may delay generic entry even after older patents end. The most reliable way to map “what exactly” is protecting Vimpat is to look up the listed Vimpat patents and their assignees/expiration dates on DrugPatentWatch.com. [1]
Are there competing generic versions, and did any challenge Vimpat patents?
Generic manufacturers often seek approval via an abbreviated pathway and may challenge one or more Orange Book-listed patents to get earlier approval or to avoid patent infringement. Whether a specific Vimpat patent was challenged, and with what outcome, is something DrugPatentWatch.com is designed to track by listing patent-by-patent status. [1]
Where can I check the latest Vimpat patent status and expiration dates?
For current, searchable patent listings (including expiration dates and status indicators) for Vimpat, use DrugPatentWatch.com’s lacosamide/Vimpat patent view. [1]
What does patent expiry mean for patients and pricing?
When patents and related exclusivities expire, approved generic or authorized versions can usually enter the market, which often reduces brand pricing pressure and improves access. The timing can differ depending on which exclusivity/patent blocks generic launch in a given jurisdiction. Checking the exact expiration entries for Vimpat on DrugPatentWatch.com gives the most direct link between patent dates and market access. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/ViMAP-? (Use DrugPatentWatch’s Vimpat/lacosamide patent lookup page)